( Excellent discussion of the challenges of conducting clinical trials in obesity ) Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP, SCALE Obesity and Prediabetes NN8022-1839 Study Group
BPC 157 exhibits anti-inflammatory properties, reducing swelling and pain in injured areas
Preclinical models have included NSAID-induced gastric mucosal damage, alcohol-induced gastric injury, restraint stress-induced lesions, inflammatory bowel disease models, and intestinal barrier permeability studies in rodent systems (1)
Weight loss injections refer to FDA-approved, prescription-only medications that are administered subcutaneously (just under the skin) on a weekly basis
Use Case: Commonly prescribed for individuals seeking to preserve existing hair Considerations: Eligibility must be determined by a licensed healthcare provider